Literature DB >> 17991338

Post-infectious irritable bowel syndrome.

Andrew W Dupont1.   

Abstract

Irritable bowel syndrome (IBS) is a common disorder associated with abdominal pain or discomfort and altered bowel habits. The majority of patients describe an insidious onset of symptoms; however, a subset report a fairly precise time of onset following an attack of acute gastroenteritis. Typically, the potential acute infectious symptoms, such as fever and vomiting, resolve after several days, but abdominal discomfort, bloating, and diarrhea persist. Although the underlying mechanism of post-infectious IBS (PI-IBS) has not been established, ongoing inflammation appears to play a role, with an increase in serotonin-containing enterochromaffin cells, T lymphocytes, mast cells, proinflammatory cytokines, and intestinal permeability. Psychiatric comorbidities are less common in PI-IBS, compared with IBS patients in general; however, the prevalence of psychological disorders is still higher compared with that in the general population and is associated with a poorer prognosis. Overall, patients with PI-IBS have a slightly improved prognosis compared with those with IBS without an infectious onset.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991338     DOI: 10.1007/s11894-007-0046-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  50 in total

1.  The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection.

Authors:  Mark R Borgaonkar; David C Ford; John K Marshall; Elizabeth Churchill; Stephen M Collins
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

2.  Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.

Authors:  B Coffin; J-P Farmachidi; P Rueegg; A Bastie; D Bouhassira
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

3.  Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni.

Authors:  Michael A Jones; Sabine Tötemeyer; Duncan J Maskell; Clare E Bryant; Paul A Barrow
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study.

Authors:  Sally D Parry; Rosamund Stansfield; Diana Jelley; Wendy Gregory; Elizabeth Phillips; J Roger Barton; Mark R Welfare
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

6.  Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

Authors:  K R Neal; L Barker; R C Spiller
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.

Authors:  John K Marshall; Marroon Thabane; Mark R Borgaonkar; Cindy James
Journal:  Clin Gastroenterol Hepatol       Date:  2007-02-06       Impact factor: 11.382

9.  Prognosis in the irritable bowel syndrome: a 5-year prospective study.

Authors:  R F Harvey; E C Mauad; A M Brown
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

10.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

View more
  14 in total

Review 1.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

2.  Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species.

Authors:  Wei Han; Xuefeng Lu; Xiaoqing Jia; Tao Zhou; Chenghao Guo
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

3.  Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?

Authors:  Shunji Ishihara; Monowar Aziz; Naoki Oshima; Yoshiyuki Mishima; Hiroshi Imaoka; Ichiro Moriyama; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2009-01-06

4.  Travel and travelers' diarrhea in patients with irritable bowel syndrome.

Authors:  Herbert L DuPont; Greg Galler; Francisco Garcia-Torres; Andrew W Dupont; Anthony Greisinger; Zhi-Dong Jiang
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

5.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

Review 6.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

7.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

Review 8.  Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-04

9.  Luminal hypertonicity and acidity modulate colorectal afferents and induce persistent visceral hypersensitivity.

Authors:  Jun-Ho La; Bin Feng; Erica S Schwartz; Pablo R Brumovsky; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-02       Impact factor: 4.052

10.  Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Authors:  Lotta Krogius-Kurikka; Anna Lyra; Erja Malinen; Johannes Aarnikunnas; Jarno Tuimala; Lars Paulin; Harri Mäkivuokko; Kajsa Kajander; Airi Palva
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.